The UK drug regulator recently approved a gene therapy for the cure of sickle cell disease and thalassaemia
This is the first licensed therapy in the world based on thegene editing technology Crispr-Cas9 that earned its innovators a Nobel Prize in 2020. About Casgevy Working of Therapy ●…